Crohn Disease: all 1,923 studies
Page 19 of 20. Open to participants first (467), then studies with results posted, then the rest; newest registration first within each.
- Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's DiseaseTerminatedNCT00562887Phase 2
- Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn DiseaseTerminatedNCT00561548Not applicable
- Top Down Versus Step Up Strategies in Crohn's DiseaseCompletedNCT00554710Phase 4
- The Crohn's Therapy, Resource, Evaluation, and Assessment Tool RegistryCompletedNCT00553176
- Early Immunosuppressants in Crohn's DiseaseCompletedNCT00546546Phase 4
- Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's DiseaseCompletedNCT00543374Phase 3
- Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's DiseaseCompletedNCT00528073Phase 2
- Cost-effectiveness of TPMT PharmacogeneticsCompletedNCT00521950Not applicable
- The Innate Immune System and Inflammatory Bowel DiseaseCompletedNCT00516776
- Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium ParatuberculosisWithdrawnNCT00513552Phase 4
- Probiotics in GastroIntestinal DisordersStatus unknownNCT00510978Phase 2/3
- Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's DiseaseCompletedNCT00509639Phase 3
- Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease ActivityCompletedNCT00496548Not applicable
- Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule EndoscopyCompletedNCT00492791
- Crohn's Disease, Obesity and Disease SeverityStatus unknownNCT00488085
- Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's DiseaseCompletedNCT00482092Phase 3
- Pregnancy Exposure Registry for Tysabri®CompletedNCT00472992
- Post-Op Quality of Life After Colorectal SurgeryCompletedNCT00468455
- An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic ColectomyCompletedNCT00467922Phase 3
- Atorvastatin in Moderate Active Crohns DiseaseCompletedNCT00454545Phase 2
- A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's DiseaseCompletedNCT00446433Phase 2
- An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.CompletedNCT00440817
- MACCS: Multicenter Australian CE in Patients With Suspected Crohn's Disease StudyCompletedNCT00434551
- High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's DiseaseTerminatedNCT00417690Phase 2
- Phase II Study of RR110 in Patients With Active Crohn's DiseaseCompletedNCT00417391Phase 2
- Use of FDG PET/CT to Evaluate Crohn DiseaseCompletedNCT00383344Phase 2
- Development of Workshop for Lifestyle Changing for Crohn's Disease Patients and Its Affect on the Disease's IndexesWithdrawnNCT00376649Not applicable
- Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn's Disease.CompletedNCT00374374Not applicable
- VSL#3 Treatment in Children With Crohn's DiseaseStatus unknownNCT00367705Phase 4
- Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI)TerminatedNCT00360022Not applicable
- A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's DiseaseWithdrawnNCT00358683Phase 3
- Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining FistulasWithdrawnNCT00354367Phase 3
- Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's DiseaseStatus unknownNCT00353756Phase 1
- Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)CompletedNCT00338650Phase 3
- Study of Sargramostim in Moderately to Severely Active Crohn's DiseaseTerminatedNCT00329537Phase 2
- Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008CompletedNCT00308438Phase 2
- A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT00306215Phase 2
- Synbiotic Treatment in Crohn's Disease PatientsCompletedNCT00305409Not applicable
- Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's DiseaseTerminatedNCT00304252Phase 2
- Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)CompletedNCT00300118Phase 3
- ASTIC Autologous Stem Cell Transplantation for Crohn's DiseaseTerminatedNCT00297193Phase 3
- Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseTerminatedNCT00295165Phase 3
- Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's DiseaseCompletedNCT00294112Phase 2
- Early Alimentation Following Colorectal SurgeryStatus unknownNCT00290524Phase 3
- Glucocorticoid-induced Osteopenia in ChildrenCompletedNCT00289328
- Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's DiseaseCompletedNCT00287170Phase 1/2
- Effects of Growth Hormone in Chronically Ill ChildrenWithdrawnNCT00286689Not applicable
- Open Label Natalizumab Safety Extension Study for Subjects With Crohn's DiseaseCompletedNCT00280956Phase 4
- Hematopoietic Stem Cell Support in Patients With Severe Crohn's DiseaseTerminatedNCT00278577Phase 1
- Beta Carotene From Natural Source for Patients With Non-Active Crohn's DiseaseStatus unknownNCT00275418Phase 3
- Chromoendoscopy for Ulcerative Colitis SurveillanceCompletedNCT00274209
- An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's DiseaseCompletedNCT00269854Phase 2/3
- An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's DiseaseCompletedNCT00269841Phase 3
- Clarithromycin in Active Crohn's DiseaseCompletedNCT00269386Phase 3
- Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's DiseaseCompletedNCT00267722Phase 2
- Visilizumab for Treatment of Perianal Fistulas in Crohn's DiseaseCompletedNCT00267709Phase 2
- Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular BasisStatus unknownNCT00265772Phase 4
- A Long-term Safety Study of Infliximab (Remicade)CompletedNCT00261976
- Study of Antibiotics in the Treatment of Colonic Crohn's DiseaseTerminatedNCT00257699Phase 2
- Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.TerminatedNCT00252369Not applicable
- The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's DiseaseCompletedNCT00250198Phase 2
- Study Evaluating ERB-041 in Active Crohn's DiseaseCompletedNCT00245947Phase 1
- The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"TerminatedNCT00245505Phase 3
- Infectious Agents in Pediatric Crohn'sCompletedNCT00237055
- Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT00234741Phase 2
- A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s DiseaseCompletedNCT00225810Phase 4
- The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a AntagonistsStatus unknownNCT00224562
- Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel DiseaseCompletedNCT00222378
- Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's DiseaseCompletedNCT00221026Phase 2
- Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel DiseaseCompletedNCT00215020
- A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's DiseaseCompletedNCT00207766Phase 3
- A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's DiseaseCompletedNCT00207675Phase 3
- A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's DiseaseCompletedNCT00207662Phase 3
- Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With SargramostimTerminatedNCT00206713Phase 3
- Open-label Trial of Leukine in Active Crohn's DiseaseTerminatedNCT00206700Phase 2
- Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT00206674Phase 3
- Safety and Efficacy Study in the Treatment of Pediatric Crohn's DiseaseTerminatedNCT00206661Phase 1/2
- Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's DiseaseCompletedNCT00206596Phase 2
- Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.Status unknownNCT00204165Phase 3
- Immune Ablation and Stem Cell Support for Crohn's DiseaseWithdrawnNCT00179842Phase 2
- Wireless Capsule Endoscopy in Small-Bowel Crohn's DiseaseWithdrawnNCT00178438Phase 1/2
- A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.CompletedNCT00175292Phase 3
- The Influence of 5-Aminosalicylates on Thiopurine Metabolite LevelsCompletedNCT00167882Phase 4
- Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative ColitisTerminatedNCT00152841Phase 2
- A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)CompletedNCT00152490Phase 3
- Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).CompletedNCT00152425Phase 3
- Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease PatientsCompletedNCT00138879
- Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT00138840Phase 2
- COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)CompletedNCT00132899Phase 3
- Vitamin D Treatment for Crohn´s DiseaseStatus unknownNCT00132184Phase 2/3
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's DiseaseTerminatedNCT00130390Phase 2
- A Trial of Wellbutrin for Crohn's DiseaseCompletedNCT00126373Phase 2/3
- Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel DiseaseCompletedNCT00114803Not applicable
- VSL#3 Versus Placebo in Maintenance of Remission in Crohn's DiseaseCompletedNCT00114465Phase 4
- Imuran Dosing in Crohn's Disease StudyTerminatedNCT00113503Phase 2
- An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's DiseaseCompletedNCT00106314Phase 2
- Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00105300Phase 3
- Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's DiseaseCompletedNCT00102921Phase 2
- Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's DiseaseCompletedNCT00101946Phase 2
- Imuran (Azathioprine) Dose-Ranging Study in Crohn's DiseaseTerminatedNCT00098111Phase 3